{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:43Z","timestamp":1787020183408,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15692-1","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:37:40Z","timestamp":1775115460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical, diagnostic and prognostic relevance of GATA3 in malignant pleural mesothelioma: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Alejandro","family":"Avil\u00e9s-Salas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D\u00e1vila","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Aranda-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Nallely","family":"Heredia-Jara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Caball\u00e9-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Cabrera-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s F.","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Lucio-Lozada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Castillo-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Hernandez-Pedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"15692_CR1","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.21037\/jtd-20-2761","volume":"13","author":"SO Schumann","year":"2021","unstructured":"Schumann SO, Kocher G, Minervini F. Epidemiology, diagnosis and treatment of the malignant pleural mesothelioma, a narrative review of literature. J Thorac Dis. 2021;13:2510\u201323. https:\/\/doi.org\/10.21037\/jtd-20-2761.","journal-title":"J Thorac Dis"},{"key":"15692_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1183\/1393003.congress-2017.PA4294","volume":"50","author":"V Panou","year":"2017","unstructured":"Panou V, Weinreich UM, Bak J, Vyberg M, Meristoudis C, Omland O, et al. Gender differences in asbestos exposure and disease location in 327 patients with mesothelioma. Eur Respir J. 2017;50:61. https:\/\/doi.org\/10.1183\/1393003.congress-2017.PA4294.","journal-title":"Eur Respir J"},{"key":"15692_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01449-2","volume":"21","author":"M Kojima","year":"2020","unstructured":"Kojima M, Kajino K, Momose S, Wali N, Hlaing MT, Han B, et al. Possible reversibility between epithelioid and sarcomatoid types of mesothelioma is independent of ERC\/mesothelin expression. Respir Res. 2020;21:187. https:\/\/doi.org\/10.1186\/s12931-020-01449-2.","journal-title":"Respir Res"},{"key":"15692_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.5858\/arpa.2018-0457-OA","volume":"144","author":"N Le Stang","year":"2020","unstructured":"Le Stang N, Burke L, Blaizot G, Gibbs AR, Lebailly P, Clin B, et al. Differential diagnosis of epithelioid malignant mesothelioma with lung and breast pleural metastasis: a systematic review compared with a standardized panel of antibodies-a new proposal that may influence pathologic practice. Arch Pathol Lab Med. 2020;144:446\u201356. https:\/\/doi.org\/10.5858\/arpa.2018-0457-OA.","journal-title":"Arch Pathol Lab Med"},{"key":"15692_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119893","volume":"1872","author":"R Bacha","year":"2025","unstructured":"Bacha R, Pedersen S, Ismail R, Alwisi N, Al-Mansoori L. GATA3: orchestrating cellular fate through differentiation and proliferation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2025;1872:119893. https:\/\/doi.org\/10.1016\/j.bbamcr.2024.119893.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"15692_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000527382","volume":"90","author":"V Reiswich","year":"2023","unstructured":"Reiswich V, Schmidt CE, Lennartz M, H\u00f6flmayer D, Hube-Magg C, Weidemann S, et al. GATA3 expression in human tumors: a tissue microarray study on 16,557 tumors. Pathobiology. 2023;90:219\u201332. https:\/\/doi.org\/10.1159\/000527382.","journal-title":"Pathobiology"},{"key":"15692_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153611","volume":"226","author":"M Khazaeli Najafabadi","year":"2021","unstructured":"Khazaeli Najafabadi M, Mirzaeian E, Memar Montazerin S, Tavangar AR, Tabary M, Tavangar SM. Role of GATA3 in tumor diagnosis: a review. Pathol Res Pract. 2021;226:153611. https:\/\/doi.org\/10.1016\/j.prp.2021.153611.","journal-title":"Pathol Res Pract"},{"key":"15692_CR8","doi-asserted-by":"publisher","unstructured":"Bota E-C, Koumoundourou D, Ravazoula P, Zolota V, Psachoulia C, Kardari M, et al. A comprehensive analysis of GATA3 expression in carcinomas of various origins with emphasis on lung carcinomas. Monaldi Arch Chest Dis Arch Monaldi Mal Torace. 2023;94. https:\/\/doi.org\/10.4081\/monaldi.2023.2641.","DOI":"10.4081\/monaldi.2023.2641"},{"key":"15692_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","volume":"38","author":"M Miettinen","year":"2014","unstructured":"Miettinen M, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, et al. GATA3: A multispecific but potentially useful marker in surgical pathology A systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol. 2014;38:13\u201322. https:\/\/doi.org\/10.1097\/PAS.0b013e3182a0218f.","journal-title":"Am J Surg Pathol"},{"key":"15692_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03048-y","author":"ZH Piao","year":"2021","unstructured":"Piao ZH, Zhou XC, Chen JY. GATA3 is a useful immunohistochemical marker for distinguishing sarcomatoid malignant mesothelioma from lung sarcomatoid carcinoma and organizing pleuritis. Virchows Arch. 2021. https:\/\/doi.org\/10.1007\/s00428-021-03048-y.","journal-title":"Virchows Arch"},{"key":"15692_CR11","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.pathol.2020.01.259","volume":"52","author":"C Kim","year":"2020","unstructured":"Kim C, Prabhakaran S, Hocking A, Hussey M, Klebe S. A study of GATA-3 in malignant pleural mesothelioma. Pathol (Phila). 2020;52:S78. https:\/\/doi.org\/10.1016\/j.pathol.2020.01.259.","journal-title":"Pathol (Phila)"},{"key":"15692_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2020.08.005","volume":"105","author":"S Prabhakaran","year":"2020","unstructured":"Prabhakaran S, Hocking A, Kim C, Hussey M, Klebe S. The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas. Hum Pathol. 2020;105:1\u20138. https:\/\/doi.org\/10.1016\/j.humpath.2020.08.005.","journal-title":"Hum Pathol"},{"key":"15692_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4103\/IJPM.IJPM_228_18","volume":"62","author":"H Agarwal","year":"2019","unstructured":"Agarwal H, Babu S, Rana C, Kumar M, Singhai A, Shankhwar SN, et al. Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma. Indian J Pathol Microbiol. 2019;62:244\u201350. https:\/\/doi.org\/10.4103\/IJPM.IJPM_228_18.","journal-title":"Indian J Pathol Microbiol"},{"key":"15692_CR14","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.humpath.2010.06.010","volume":"41","author":"NK Yoon","year":"2010","unstructured":"Yoon NK, Maresh EL, Shen D, Elshimali Y, Apple S, Horvath S, et al. Higher levels of GATA3 predict better survival in women with breast cancer. Hum Pathol. 2010;41:1794\u2013801. https:\/\/doi.org\/10.1016\/j.humpath.2010.06.010.","journal-title":"Hum Pathol"},{"key":"15692_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a Bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67:93\u20139. https:\/\/doi.org\/10.3322\/caac.21388.","journal-title":"CA Cancer J Clin"},{"key":"15692_CR16","volume-title":"R: a Language and environment for statistical computing. Manual","author":"R Core Team","year":"2025","unstructured":"R Core Team. R: a Language and environment for statistical computing. Manual. Vienna, Austria: R Foundation for Statistical Computing; 2025. https:\/\/www.R-project.org\/."},{"key":"15692_CR17","doi-asserted-by":"publisher","unstructured":"Wickham H, Miller E, Smith D. haven: Import and export SPSS, stata and SAS files. manual. 2025. https:\/\/doi.org\/10.32614\/CRAN.package.haven","DOI":"10.32614\/CRAN.package.haven"},{"key":"15692_CR18","doi-asserted-by":"publisher","DOI":"10.32614\/CRAN.package.dplyr","author":"H Wickham","year":"2023","unstructured":"Wickham H, Fran\u00e7ois R, Henry L, M\u00fcller K, Vaughan D. Dplyr: a grammar of data manipulation. Manual. 2023. https:\/\/doi.org\/10.32614\/CRAN.package.dplyr.","journal-title":"Manual"},{"key":"15692_CR19","doi-asserted-by":"crossref","unstructured":"Wickham H, Vaughan D, Girlich M. tidyr: Tidy messy data. manual. 2024. https:\/\/doi.org\/10.32614\/CRAN.package.tidyr","DOI":"10.32614\/CRAN.package.tidyr"},{"key":"15692_CR20","unstructured":"Gordon M, Lumley T, forestplot. Advanced forest plot using grid graphics. manual. 2025."},{"key":"15692_CR21","unstructured":"Therneau TM. A package for survival analysis in R. 2024. https:\/\/CRAN.R-project.org\/package=survival"},{"key":"15692_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer-; 2016. https:\/\/ggplot2.tidyverse.org."},{"key":"15692_CR23","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.21105\/joss.02017","volume":"5","author":"JC Brunson","year":"2020","unstructured":"Brunson JC. Ggalluvial: layered grammar for alluvial plots. J Open Source Softw. 2020;5:2017. https:\/\/doi.org\/10.21105\/joss.02017.","journal-title":"J Open Source Softw"},{"key":"15692_CR24","unstructured":"Sjoberg DD, Baillie M, Fruechtenicht C, Haesendonckx S, Treis T. ggsurvfit: Flexible time-to-event figures. manual. 2025. https:\/\/CRAN.R-project.org\/package=ggsurvfit"},{"key":"15692_CR25","doi-asserted-by":"publisher","first-page":"7881","DOI":"10.1093\/bioinformatics\/bti623","volume":"21","author":"T Sing","year":"2005","unstructured":"Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinforma Oxf Engl. 2005;21:7881. https:\/\/doi.org\/10.1093\/bioinformatics\/bti623.","journal-title":"Bioinforma Oxf Engl"},{"key":"15692_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5858\/arpa.2019-0647-OA","volume":"145","author":"SBSP Terra","year":"2021","unstructured":"Terra SBSP, Roden AC, Aubry MC, Yi ES, Joanne, Boland JM. Utility of immunohistochemistry for MUC4 and GATA3 to aid in the distinction of pleural sarcomatoid mesothelioma from pulmonary sarcomatoid carcinoma. Arch Pathol Lab Med. 2021;145:208\u201313. https:\/\/doi.org\/10.5858\/arpa.2019-0647-OA.","journal-title":"Arch Pathol Lab Med"},{"key":"15692_CR27","doi-asserted-by":"publisher","first-page":"107511","DOI":"10.1016\/j.rmed.2023.107511","volume":"222","author":"AMH Khan","year":"2024","unstructured":"Khan AMH, Anwer SH, Sayed S, Mansha MA, Kamran YB, Khursheed A, et al. Comprehensive clinical overview of malignant pleural mesothelioma. Respir Med. 2024;222:107511. https:\/\/doi.org\/10.1016\/j.rmed.2023.107511.","journal-title":"Respir Med"},{"key":"15692_CR28","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S1470-2045(13)70257-2","volume":"14","author":"F Baumann","year":"2013","unstructured":"Baumann F, Ambrosi J-P, Carbone M. Asbestos is not just asbestos: an unrecognised health hazard. Lancet Oncol. 2013;14:576\u20138. https:\/\/doi.org\/10.1016\/S1470-2045(13)70257-2.","journal-title":"Lancet Oncol"},{"key":"15692_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.thorsurg.2020.08.005","volume":"30","author":"B Wadowski","year":"2020","unstructured":"Wadowski B, De Rienzo A, Bueno R. The molecular basis of malignant pleural mesothelioma. Thorac Surg Clin. 2020;30:383\u201393. https:\/\/doi.org\/10.1016\/j.thorsurg.2020.08.005.","journal-title":"Thorac Surg Clin"},{"key":"15692_CR30","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1097\/PAS.0000000000000825","volume":"41","author":"KB Berg","year":"2017","unstructured":"Berg KB, Churg A. GATA3 immunohistochemistry for distinguishing sarcomatoid and desmoplastic mesothelioma from sarcomatoid carcinoma of the lung. Am J Surg Pathol. 2017;41:1221\u20135. https:\/\/doi.org\/10.1097\/PAS.0000000000000825.","journal-title":"Am J Surg Pathol"},{"key":"15692_CR31","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.humpath.2014.03.006","volume":"45","author":"NG Ord\u00f3\u00f1ez","year":"2014","unstructured":"Ord\u00f3\u00f1ez NG, Sahin AA. Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study. Hum Pathol. 2014;45:1529\u201340. https:\/\/doi.org\/10.1016\/j.humpath.2014.03.006.","journal-title":"Hum Pathol"},{"key":"15692_CR32","doi-asserted-by":"publisher","first-page":"e87195","DOI":"10.1371\/journal.pone.0087195","volume":"9","author":"RP Keshari","year":"2014","unstructured":"Keshari RP, Wang W, Zhang Y, Wang D, Li Y, Yuan S, et al. Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinoma. PLoS ONE. 2014;9:e87195. https:\/\/doi.org\/10.1371\/journal.pone.0087195.","journal-title":"PLoS ONE"},{"key":"15692_CR33","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.urolonc.2016.04.016","volume":"34","author":"KH Mohammed","year":"2016","unstructured":"Mohammed KH, Siddiqui MT, Cohen C. GATA3 immunohistochemical expression in invasive urothelial carcinoma. Urol Oncol Semin Orig Investig. 2016;34:432.e9-432.e13. https:\/\/doi.org\/10.1016\/j.urolonc.2016.04.016.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"15692_CR34","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3390\/medicina59081452","volume":"59","author":"D Yoo","year":"2023","unstructured":"Yoo D, Min K-W, Pyo J-S, Kim NY. Diagnostic and prognostic roles of GATA3 immunohistochemistry in urothelial carcinoma. Med Kaunas Lith. 2023;59:1452. https:\/\/doi.org\/10.3390\/medicina59081452.","journal-title":"Med Kaunas Lith"},{"key":"15692_CR35","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.humpath.2013.05.022","volume":"44","author":"HE Gulbahce","year":"2013","unstructured":"Gulbahce HE, Sweeney C, Surowiecka M, Knapp D, Varghese L, Blair CK. Significance of GATA-3 expression in outcomes of patients with breast cancer who received systemic chemotherapy and\/or hormonal therapy and clinicopathologic features of GATA-3-positive tumors. Hum Pathol. 2013;44:2427\u201331. https:\/\/doi.org\/10.1016\/j.humpath.2013.05.022.","journal-title":"Hum Pathol"},{"key":"15692_CR36","doi-asserted-by":"publisher","first-page":"17795","DOI":"10.1038\/s41598-024-68788-8","volume":"14","author":"X Chen","year":"2024","unstructured":"Chen X, Zhao W, Huang Y, Luo S, Tang X, Yi Q. Association of GATA3 expression in triple-positive breast cancer with overall survival and immune cell infiltration. Sci Rep. 2024;14:17795. https:\/\/doi.org\/10.1038\/s41598-024-68788-8.","journal-title":"Sci Rep"},{"key":"15692_CR37","doi-asserted-by":"publisher","first-page":"e0156524","DOI":"10.1371\/journal.pone.0156524","volume":"11","author":"T Haraguchi","year":"2016","unstructured":"Haraguchi T, Miyoshi H, Hiraoka K, Yokoyama S, Ishibashi Y, Hashiguchi T, et al. GATA3 expression is a poor prognostic factor in soft tissue sarcomas. PLoS ONE. 2016;11:e0156524. https:\/\/doi.org\/10.1371\/journal.pone.0156524.","journal-title":"PLoS ONE"},{"key":"15692_CR38","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/jclinpath-2021-208035","volume":"76","author":"Z Chi","year":"2023","unstructured":"Chi Z, Balani J, Gopal P, Hammer S, Xu J, Peng L. GATA3 positivity is associated with poor prognosis in patients with oesophageal squamous cell carcinoma. J Clin Pathol. 2023;76:474\u20139. https:\/\/doi.org\/10.1136\/jclinpath-2021-208035.","journal-title":"J Clin Pathol"},{"key":"15692_CR39","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1038\/onc.2017.8","volume":"36","author":"M-C Lin","year":"2017","unstructured":"Lin M-C, Lin J-J, Hsu C-L, Juan H-F, Lou P-J, Huang M-C. GATA3 interacts with and stabilizes HIF-1\u03b1 to enhance cancer cell invasiveness. Oncogene. 2017;36:4243\u201352. https:\/\/doi.org\/10.1038\/onc.2017.8.","journal-title":"Oncogene"},{"key":"15692_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.humpath.2017.02.024","volume":"63","author":"T Hashiguchi","year":"2017","unstructured":"Hashiguchi T, Miyoshi H, Nakashima K, Yokoyama S, Matsumoto R, Murakami D, et al. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma. Hum Pathol. 2017;63:157\u201364. https:\/\/doi.org\/10.1016\/j.humpath.2017.02.024.","journal-title":"Hum Pathol"},{"key":"15692_CR41","doi-asserted-by":"publisher","first-page":"14042","DOI":"10.1074\/jbc.M110.105262","volume":"285","author":"W Yan","year":"2010","unstructured":"Yan W, Cao QJ, Arenas RB, Bentley B, Shao R. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J Biol Chem. 2010;285:14042\u201351. https:\/\/doi.org\/10.1074\/jbc.M110.105262.","journal-title":"J Biol Chem"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15692-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15692-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15692-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T08:08:05Z","timestamp":1775549285000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15692-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15692"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15692-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective observational study was conducted in compliance with the principles of the 1964 Declaration of Helsinki and its later amendments, following local laws and all applicable regulatory requirements for observational studies. This study was approved by the ethics and research committees at the\n                      Instituto Nacional de Cancerolog\u00eda\n                      of Mexico (CI\/0677\/2022)(CE\/2022\/118). Owing to the retrospective nature of the study, the use of disidentified data, and the absence of risks to the participants, the requirement for obtaining written informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"436"}}